Catheter Precision (VTAK) Accumulated Expenses (2017 - 2026)

Catheter Precision (VTAK) has reported Accumulated Expenses for 10 consecutive years, with $260000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 145.28% year-over-year to $260000.0; the TTM figure through Mar 2026 stood at $260000.0 (up 145.28% YoY), while the FY2025 annual figure was $1.7 million, up 9.63% from the prior year.
• Accumulated Expenses fell to $260000.0 in Q1 2026 per VTAK's latest filing, from $1.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $7.5 million in Q4 2022 and bottomed at $17000.0 in Q3 2023.
• Historically, Accumulated Expenses has averaged $1.7 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2023 — Accumulated Expenses sank 99.31% — and 2025, when it soared 4636.36%.
• Catheter Precision's Accumulated Expenses stood at $7.5 million in 2022, then slumped by 76.84% to $1.7 million in 2023, then retreated by 10.68% to $1.5 million in 2024, then climbed by 9.63% to $1.7 million in 2025, then plunged by 84.68% to $260000.0 in 2026.
• Business Quant data shows VTAK's Accumulated Expenses at $260000.0 in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.